Silgram - Infections caused by susceptible microorganisms. Typical indications are upper and lower respiratory tract infections including sinusitis, otitis media, epiglottitis and tonsillitis ; bacterial pneumonias; urinary tract infections and pyelonephritis ; intra-abdominal infections including peritonitis, cholecystitis, endometritis and pelvic cellulitis ; bacterial septicemia ; skin, soft tissue, bone and joint infections and gonococcal infections. Unasyn Tablet/Suspension may also be indicated in patients requiring sulbactam/ampicillin therapy following initial treatment with Unasyn IM/IV. Sulbactam sodium/ampicillin sodium IM/IV may also be administered perioperatively to reduce the incidence of postoperative wound infections in patients undergoing abdominal or pelvic surgery, in which peritoneal contamination may be present. In termination of pregnancy or cesarean section, Silgram may be used prophylactically to reduce postoperative sepsis.
For infections caused by susceptible microorganisms. Typical indications are upper and lower respiratory tract infections including sinusitis, otitis media and epiglottitis ; bacterial pneumonias; urinary tract infections and pyelonephritis ; intra-abdominal infections including peritonitis, cholecystitis, endometritis and pelvic cellulitis ; bacterial septicaemia ; skin, soft tissue, bone and joint infections and gonococcal infections. Silgram may also be administered preoperatively to reduce the incidence of postoperative wound infections in patients undergoing abdominal or pelvic surgery, in which peritoneal contamination may be present. In termination of pregnancy or caesarean section, Silgram may be used prophylactically to reduce postoperative sepsis.
Infections caused by susceptible microorganisms. Typical indications are upper and lower respiratory tract infections including sinusitis, otitis media and epiglottitis; bacterial pneumonias; urinary tract infections and pyelonephritis; intra-abdominal infections including peritonitis; cholecystitis; endometritis and pelvic cellulitis; bacterial septicaemia; skin, soft tissue, bone and joint infections and gonococcal infections. Silgram may also be administered perioperatively to reduce the incidence of postoperative wound infections in patients undergoing abdominal or pelvic surgery, in which peritoneal contamination may be present. In termination of pregnancy or caesarean section, Silgram may be used prophylactically to reduce postoperative sepsis. |